
Sign up to save your podcasts
Or


Interviewed by Sisterhood editorial board member Sheila Gujrathi, Kiran Mazumdar-Shaw describes her beginnings in designing enzymes, and eventually pioneering biologics and biosimilars after an initial success in making recombinant human insulin for the India market. She discusses her emphasis on affordable innovation and shares business learnings from her career.
By BiotechTV5
22 ratings
Interviewed by Sisterhood editorial board member Sheila Gujrathi, Kiran Mazumdar-Shaw describes her beginnings in designing enzymes, and eventually pioneering biologics and biosimilars after an initial success in making recombinant human insulin for the India market. She discusses her emphasis on affordable innovation and shares business learnings from her career.

1,863 Listeners

56,404 Listeners

325 Listeners

6,059 Listeners

86 Listeners

34 Listeners

19 Listeners

0 Listeners

4 Listeners

6 Listeners

5 Listeners